Literature DB >> 22488901

Nanoformulations for molecular MRI.

Chuqiao Tu1, Angelique Y Louie.   

Abstract

Nanoscale contrast agents have shown the ability to increase the detection sensitivity of magnetic resonance imaging (MRI) by several orders of magnitude, endowing this traditionally macroscopic modality with the ability to observe unique molecular signatures. Herein, we describe three types of nanoparticulate contrast agents: iron oxide nanoparticles, n class="Chemical">gadolinium-based nanoparticles, and bio-essential manganese, cobalt, nickel, and copper ion-containing nanoformulations. Some of these agents have been approved for clinical use, but more are still under development for medical imaging. The advantages and disadvantages of each nanoformulation, in terms of intrinsic magnetism, ease of synthesis, biodistribution, etc. are discussed.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488901      PMCID: PMC3380179          DOI: 10.1002/wnan.1170

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  52 in total

Review 1.  Revisiting an old friend: manganese-based MRI contrast agents.

Authors:  Dipanjan Pan; Shelton D Caruthers; Angana Senpan; Ann H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010-09-21

2.  Receptor-targeted iron oxide nanoparticles for molecular MR imaging of inflamed atherosclerotic plaques.

Authors:  Chuqiao Tu; Thomas S C Ng; Hargun K Sohi; Heather A Palko; Adrian House; Russell E Jacobs; Angelique Y Louie
Journal:  Biomaterials       Date:  2011-07-13       Impact factor: 12.479

3.  Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus.

Authors:  Dipanjan Pan; Shelton D Caruthers; Angana Senpan; Ceren Yalaz; Allen J Stacy; Grace Hu; Jon N Marsh; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Journal:  J Am Chem Soc       Date:  2011-05-26       Impact factor: 15.419

4.  Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.

Authors:  Kui Luo; Gang Liu; Wenchuan She; Qiaoying Wang; Gang Wang; Bin He; Hua Ai; Qiyong Gong; Bin Song; Zhongwei Gu
Journal:  Biomaterials       Date:  2011-07-23       Impact factor: 12.479

Review 5.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

6.  Catalytic synthesis of amino acid and peptide derivatized gadonanotubes.

Authors:  Yuri Mackeyev; Keith B Hartman; Jeyarama S Ananta; Adrian V Lee; Lon J Wilson
Journal:  J Am Chem Soc       Date:  2009-06-24       Impact factor: 15.419

7.  Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking.

Authors:  Margherita Neri; Claudio Maderna; Chiara Cavazzin; Vivien Deidda-Vigoriti; Letterio S Politi; Giuseppe Scotti; Pasquina Marzola; Andrea Sbarbati; Angelo L Vescovi; Angela Gritti
Journal:  Stem Cells       Date:  2007-11-01       Impact factor: 6.277

8.  Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging.

Authors:  Benjamin R Jarrett; Björn Gustafsson; David L Kukis; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2008-06-26       Impact factor: 4.774

9.  Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging.

Authors:  Keith B Hartman; Sabrina Laus; Robert D Bolskar; Raja Muthupillai; Lothar Helm; Eva Toth; Andre E Merbach; Lon J Wilson
Journal:  Nano Lett       Date:  2008-01-24       Impact factor: 11.189

Review 10.  Dendrimers in medical nanotechnology.

Authors:  Tristan Barrett; Gregory Ravizzini; Peter L Choyke; Hisataka Kobayashi
Journal:  IEEE Eng Med Biol Mag       Date:  2009 Jan-Feb
View more
  7 in total

1.  Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lung.

Authors:  Kristan L S Worthington; Andrea Adamcakova-Dodd; Amaraporn Wongrakpanich; Imali A Mudunkotuwa; Kranti A Mapuskar; Vijaya B Joshi; C Allan Guymon; Douglas R Spitz; Vicki H Grassian; Peter S Thorne; Aliasger K Salem
Journal:  Nanotechnology       Date:  2013-09-05       Impact factor: 3.874

2.  Multimodality PET/MRI agents targeted to activated macrophages.

Authors:  Chuqiao Tu; Thomas S C Ng; Russell E Jacobs; Angelique Y Louie
Journal:  J Biol Inorg Chem       Date:  2013-10-29       Impact factor: 3.358

Review 3.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

4.  The nanomedicine revolution: part 2: current and future clinical applications.

Authors:  C Lee Ventola
Journal:  P T       Date:  2012-10

Review 5.  Strategies for the development of gadolinium-based 'q'-activatable MRI contrast agents.

Authors:  Chuqiao Tu; Angelique Y Louie
Journal:  NMR Biomed       Date:  2012-09-27       Impact factor: 4.044

6.  Tracking of magnetite labeled nanoparticles in the rat brain using MRI.

Authors:  Naira P Martínez Vera; Reinhold Schmidt; Klaus Langer; Iavor Zlatev; Robert Wronski; Ewald Auer; Daniel Havas; Manfred Windisch; Hagen von Briesen; Sylvia Wagner; Julia Stab; Motti Deutsch; Claus Pietrzik; Franz Fazekas; Stefan Ropele
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

Review 7.  A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics.

Authors:  Pedro Farinha; João M P Coelho; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Nanomaterials (Basel)       Date:  2021-12-17       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.